TITLE

SAFETY AND EFFECTIVENESS OF THE NEW INACTIVATED HEPATITIS A VIRUS VACCINE

AUTHOR(S)
Furesz, John; Scheifele, David W.; Palkonyay, Laszlo
PUB. DATE
February 1995
SOURCE
CMAJ: Canadian Medical Association Journal;2/1/1995, Vol. 152 Issue 3, p343
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35492252

 

Related Articles

  • Safety and Immunogenicity of Hepatitis A Vaccine in Human Immunodeficiency Virus-Infected Patients: A Double-Blind, Randomized, Placebo-Controlled Trial. Kemper, Carol A.; Haubrich, Richard; Frank, Ian; Dubin, Gary; Buscarino, Charles; McCutchan, J. Allen; Deresinski, Stanley C. // Journal of Infectious Diseases;4/15/2003, Vol. 187 Issue 8, p1327 

    Evaluates the safety and immunogenicity of inactivated hepatitis A (HepA) vaccine in hepatitis A virus-seronegative, human immunodeficiency virus (HIV)-infected adults. Random assignment of patients to receive either two doses of vaccine or placebo; Observation that HepA vaccine was well...

  • Japanese Encephalitis Vaccine (Inactivated, Adsorbed) [IXIARO]. Duggan, Sean T.; Plosker, Greg L. // Drugs;2009, Vol. 69 Issue 1, p115 

    ▴ The Japanese encephalitis vaccine IC-51 (IXIARO®) is an inactivated virus (strain SA14-14-2) that is manufactured in cultured Vero cells and is currently being developed for preventive vaccination against the Japanese encephalitis virus. ▴ Administration of IXIARO® as a...

  • Development of inactivated Akabane and bovine ephemeral fever vaccine for cattle. Dong-Kun Yang; Ha-Hyun Kim; Hyun-Ye Jo; Sung-Suk Choi; In-Soo Cho // Korean Journal of Veterinary Research;2015, Vol. 55 Issue 4, p227 

    Akabane and bovine ephemeral fever (BEF) viruses cause vector-borne diseases. In this study, inactivated Akabane virus (AKAV)+Bovine ephemeral fever virus (BEFV) vaccines with or without recombinant vibrio flagellin (revibFlaB) protein were expressed in a baculovirus expression system to measure...

  • Science Does Not Support The Flu Shot Recommendations.  // HealthFacts;Nov2006, Vol. 31 Issue 11, p5 

    The article discusses research on the safety and efficacy of annual flu vaccine. It tackles the benefits of influenza vaccine to healthy adults and children. It also addresses the serious adverse effects of the vaccine. A new report explains that the systematic reviews show a consistent pattern...

  • Requirements for improved vaccines against foot-and-mouth disease epidemics. Jong-Hyeon Park // Clinical & Experimental Vaccine Research;Jan2013, Vol. 2 Issue 1, p8 

    Inactivated foot-and-mouth disease (FMD) vaccines are currently used worldwide. With the emergence of various FMD virus serotypes and subtypes, vaccines must become more suitable for field-based uses under the current circumstances in terms of the fast and proper selection of vaccine strains, an...

  • Global Advisory Committee on Vaccine Safety, 3-4 December 2003.  // Weekly Epidemiological Record;1/16/2004, Vol. 79 Issue 3, p16 

    Reports on the ninth meeting of Global Advisory Committee on Vaccine Safety (GACVS) held in Geneva, Switzerland on 3-4 December, 2003. Consideration of safety issues related with new generation influenza vaccine administered by intranasal route; Review of four neurological complications in...

  • Research updates of vaccines against avian influenza virus. TAN Wei; XIE Li-ji; XIE Zhi-xun // Journal of Southern Agriculture;2014, Vol. 45 Issue 8, p1492 

    Vaccination is still one of the most effective ways to control and prevent influenza virus infections. To date, there are four types of commonly-used vaccination strategies: emergency vaccination, preventive vaccination, systematic vaccination, and alternative vaccination. The major types of...

  • Downstream processing of viral vectors and vaccines. Morenweiser, R // Gene Therapy;Oct2005, Vol. 12, pS103 

    Viral vectors and viral vaccines more and more play an important role in current medical approaches. Gene vectors like adenoviruses, adeno-associated viruses or retroviruses are the vehicles being developed for delivering genetic material to the target cell in gene therapy. Viral vaccines, like...

  • The Changing Epidemiology of Hepatitis A Virus Infections in the United States. Nelson, Kenrad E. // Journal of Infectious Diseases;7/15/2015, Vol. 212 Issue 2, p171 

    The article offers information on the changing epidemiology of hepatitis A Virus (HAV) infections in the U.S. Topics discussed include decline in the incidence of HAV infection in the country, low adoption rate of HAV vaccines in various countries despite its effectiveness and safety, and...

  • Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Polack, Fernando P.; Lee, Sok H.; Permar, Sallie; Manyara, Elizabeth; Nousari, Hossein G.; Jeng, Yaikah; Mustafa, Farah; Valsamakis, Alexandra; Adams, Robert J.; Robinson, Harriet L.; Griffin, Diane E. // Nature Medicine;Jul2000, Vol. 6 Issue 7, p776 

    Measles remains a principal cause of worldwide mortality, in part because young infants cannot be immunized effectively. Development of new vaccines has been hindered by previous experience with a formalin-inactivated vaccine that predisposed to a severe form of disease (atypical measles). Here...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics